skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
11230806
Filing Dt:
09/20/2005
Publication #:
Pub Dt:
10/04/2007
Inventors:
Steven Regen, Betsy C. Herold
Title:
Sulfated molecular umbrellas as anti-HIV and anti-HSV agents
Assignment: 1
Reel/Frame:
016739/0021Recorded: 11/07/2005Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/14/2005
Exec Dt:
10/25/2005
Assignees:
354 WHITAKER LABORATORY
5 EAST PACKER AVENUE
BETHLEHEM, PENNSYLVANIA 18015
ONE GUSTAVE L. LEVY PLACE
BOX 1675
NEW YORK, NEW YORK 10029
Correspondent:
PHILIP E. HANSEN
HESLIN ROTHENBERG FARLEY & MESITI, P.C.
5 COLUMBIA CIRCLE
ALBANY, NY 12203
Assignment: 2
Reel/Frame:
024564/0052Recorded: 06/21/2010Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/19/2010
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980
Assignment: 3
Reel/Frame:
043120/0925Recorded: 07/27/2017Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/31/2017
Assignee:
6705 ROCKLEDGE DRIVE
BETHESDA, MARYLAND 20892-7974
Correspondent:
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLACE
BOX 1675
NEW YORK, NY 10029

Search Results as of: 04/29/2024 06:21 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT